49 studies found for:    Open Studies | "Vision Disorders"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Visual Quality Change of Eyes Implanted With Diffractive Multifocal Intraocular Lens After Cataract Surgery
Conditions: Dry Eye;   Vision Disorders;   Quality of Life
Intervention: Other: Diffractive multifocal IOLs group
2 Unknown  Utility of a Survey Instrument to Predict Benefit From a Novel Treatment for Vertical Heterophoria
Conditions: Binocular Vision Dysfunction;   Vertical Heterophoria
Intervention: Other: Questionnaires and Optometrist Prism Challenge/Treatment
3 Recruiting Ranibizumab Treatment for Age-Related Macular Degeneretion
Condition: Visual Disorder Due to Age-related Macula Degeneration
Intervention: Drug: Intravitreal Lucentis 0.5mg
4 Recruiting Study and Treatment of Visual Dysfunction and Motor Fatigue in Multiple Sclerosis
Conditions: Multiple Sclerosis;   Internuclear Ophthalmoplegia
Interventions: Drug: Dalfampridine;   Drug: Placebo
5 Not yet recruiting Systemic VEGF Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
Condition: Visual Impairment Due to Diabetic Macular Edema
Interventions: Drug: Ranibizumab;   Drug: Aflibercept
6 Recruiting Efficacy and Safety of Ranibizumab 0.5 vs Veteporfin PDT in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia
Condition: Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia
Interventions: Drug: Ranibizumab 0.5mg;   Drug: Rranibizumab 0.5 mg;   Drug: Verteporfin PDT
7 Recruiting Interferon Gamma-1b Administered Topically for Macular Edema/Intraretinal Schisis Cysts in Rod-Cone Dystrophy (RCD) and Enhanced S-Cone Syndrome (ESCS)
Conditions: Inherited Ophthalmic Diseases;   Inherited Retinal Degeneration
Intervention: Drug: Interferon gamma-1b
8 Unknown  Prevalence Study of Adrenal Suppression After Corticosteroids During Chemotherapy.
Condition: Adrenal Suppression
Intervention: Other: Prevalence study only, no study intervention
9 Recruiting Clinical and Genetic Characterization of Individuals With Achromatopsia
Condition: Achromatopsia
Intervention:
10 Unknown  Clinical Effectiveness of Low Vision Rehabilitation in Glaucoma Patients
Condition: Glaucoma
Interventions: Device: portable CCTV;   Device: Telescopes, telemicroscopes and microscopes;   Device: Absorptive filters
11 Recruiting Efficacy of Enhancing Low Vision Mobility Thru Visual Training in Virtual World
Condition: Low Vision
Intervention:
12 Recruiting Visual Perceptual Learning for the Treatment of Visual Field Defect
Conditions: Stroke;   Visual Field Defect
Intervention: Behavioral: Visual perceptual learning
13 Recruiting Dichoptic Virtual Reality Therapy for Amblyopia in Adults
Conditions: Amblyopia;   Anisometropia;   Strabismus
Interventions: Device: Dichoptic therapy;   Other: Patching therapy;   Device: Dioptic (non-dichoptic) therapy
14 Recruiting Living Successfully With Chronic Eye Diseases
Conditions: Chronic Diseases;   Low Vision;   Diabetic Retinopathy;   Glaucoma;   Age-related Macular Degeneration
Intervention: Behavioral: Low Vision Self-Management Program
15 Recruiting Visual and Functional Assessment in Low Vision Patients
Conditions: Retinitis Pigmentosa;   Age-related Macular Degeneration;   Optic Nerve Pathology;   Inherited Retinal Dystrophies
Intervention:
16 Recruiting A Study to Evaluate the BrainPort Vision Device in Individuals Blinded by Traumatic Injury
Condition: Blindness
Intervention: Device: BrainPort V200 Device
17 Recruiting Assessment of Device for Treatment of Amblyopia
Condition: Amblyopia
Intervention: Device: Daily watching videos using Reviview™, a dichoptic video display device, for 60 min
18 Unknown  Investigation of Biomarkers in Susac Syndrome
Condition: Susac Syndrome
Intervention:
19 Recruiting Retinal Imaging of Subjects Implanted With Ciliary Neurotrophic Factor (CNTF)-Releasing Encapsulated Cell Implant for Early-stage Retinitis Pigmentosa
Conditions: Retinitis Pigmentosa;   Usher Syndrome Type 2;   Usher Syndrome Type 3
Intervention: Drug: NT-501
20 Recruiting Rehabilitation For Acquired Visual Field Defects: Development Of A Bottom-Up Approach
Condition: Acquired Visual Field Defects
Interventions: Other: Treatment A;   Other: Treatment B

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years